Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Specialties
Publications
Articles from Mary Thompson:
Read all from this author
Business Strategies

Type 2 Era Poised to Transform US Insulin Pump Market

  • 2025-04-21 00:00:00.0
  • Mary Thompson
  • MedTech Strategist

Insulet and Tandem Diabetes Care now have FDA clearance to market their automated insulin delivery systems on-label in the US for type 2 diabetes, and more—including Medtronic, Beta Bionics, and Sequel Med Tech—are likely to follow, ushering in a new era of growth and innovation in the insulin pump industry.

Read Article